Apple: waiting for the big thing

Results beat expectations but next big product remains an unknown

US natural gas: storing up problems

Cold winter promises a hot year ahead for the sector

Newmont / Barrick Gold: lustre

Synergies – compared with valuations – may revive merger

AB Foods: UK retailers in the US

Given history of British retail failures in the US, why is Primark going to Boston?

LG Display: crystal unclear

Display companies remain short-term trades, not investments

Asia IPOs: private equity block

Getting into deals remains easier than getting out of them

Harley-Davidson: hog heaven

Group is pushing its bikes on new customers – and it is working

Valeant / Allergan: crow’s feet

A pharma deal with some wrinkles to smooth out to prolong the life of cash flows

GSK / Novartis: big renovation

Asset reshuffle should help both sides

Eli Lilly: animal spirits

Drugmaker has bought stability but diabetes is key to growth